| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesiology; University of Virginia Health System; Charlottesville, VA; pjb8y{at}virginia.edu
To the Editor:
Habib et al.s study (1) advocates the use of intrathecal morphine for postoperative pain relief after bilateral postpartum tubal ligation. There are several limitations to their study, however. The power of the study was only 80%. In addition, their dose of IV ketorolac was only 30 mg. Previous studies (2) using 60 mg of ketorolac in patients undergoing abdominal hysterectomies have indicated that the larger dose is more effective at reducing postoperative IV morphine requirements without increasing side effects. In addition, the incidence of vomiting and pruritus were significantly more likely in the treatment group in Habib et al.s study. Although delayed respiratory depression is unlikely in patients receiving small-dose intrathecal morphine, this possibility was not considered in their study. I would suggest that improved postoperative pain relief without the increased incidence of nausea and vomiting might be more effectively achieved by using 60 mg of IV ketorolac preoperatively and eliminating the intrathecal morphine. The use of the larger dose of ketorolac, combined with infiltration of ropivacaine by the obstetricians during closure, might well provide superior postoperative pain relief without the side effects associated with intrathecal morphine.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|